Aiko Nagayama
- Oncology top 10%
- Cancer Research
- Radiology, Nuclear Medicine and Imaging
- Pulmonary and Respiratory Medicine
- Molecular Biology
- Co-authors
- Aditya BardiaLeif W. EllisenNeelima VidulaBruce A. ChabnerMaiko TakahashiTetsu HayashidaTomoko SekiYuko Kitagawa
- Topics
- HER2/EGFR in Cancer Research (13 papers)Cancer Treatment and Pharmacology (9 papers)Breast Cancer Treatment Studies (9 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Aiko Nagayama
22 papers receiving 392 citations
Peers
Comparison fields: 5 of 63
- Oncology 274
- Cancer Research 100
- Radiology, Nuclear Medicine and Imaging 97
- Pulmonary and Respiratory Medicine 92
- Molecular Biology 74
Countries citing papers authored by Aiko Nagayama
This map shows the geographic impact of Aiko Nagayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aiko Nagayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aiko Nagayama more than expected).
Fields of papers citing papers by Aiko Nagayama
This network shows the impact of papers produced by Aiko Nagayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aiko Nagayama. The network helps show where Aiko Nagayama may publish in the future.
Co-authorship network of co-authors of Aiko Nagayama
This figure shows the co-authorship network connecting the top 25 collaborators of Aiko Nagayama. A scholar is included among the top collaborators of Aiko Nagayama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aiko Nagayama. Aiko Nagayama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 6 | |
| 4 | 2 | |
| 5 | 0 | |
| 6 | 8 | |
| 7 | 0 | |
| 8 | 7 | |
| 9 | 3 | |
| 10 | 21 | |
| 11 | 5 | |
| 12 | 13 | |
| 13 | 31 | |
| 14 | 8 | |
| 15 | 19 | |
| 16 | 2 | |
| 17 | 32 | |
| 18 | 2 | |
| 19 | 3 | |
| 20 | 57 |
About Aiko Nagayama
Aiko Nagayama is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 27 papers that have together received 394 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (13 papers), Cancer Treatment and Pharmacology (9 papers) and Breast Cancer Treatment Studies (9 papers). The work is most often cited by research in Oncology (274 citations), Cancer Research (100 citations) and Radiology, Nuclear Medicine and Imaging (97 citations). Aiko Nagayama has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Aditya Bardia, Leif W. Ellisen, Neelima Vidula, Bruce A. Chabner, Maiko Takahashi, Tetsu Hayashida, Tomoko Seki, Yuko Kitagawa, Akiko Matsumoto and Hiromitsu Jinno. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Cancer Research and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.